Murder Trial Update: Luigi Mangione’s Defense Strategy Shifts

Just a day after announcing plans to pursue a psychiatric defense, Luigi Mangione’s legal team has unexpectedly changed direction regarding the upcoming murder trial for the death of UnitedHealthcare CEO Brian Thompson. This information comes from recent court documents.

In a brief memo submitted to Judge Gregory Caro, Mangione’s attorney Karen Friedman Agnifilo stated that the defense had “respectfully withdrawn” its notice under New York’s psychiatric defense law. This abrupt decision has drawn attention from the legal community.

The decision signifies a notable change in a case that had previously hinted at the potential for an “extreme mental disorder” defense. If accepted, this strategy could have transformed a murder charge into a manslaughter conviction under New York law.

However, legal experts have suggested that such a defense would have required the attorneys to convince jurors that Thompson was in a state of “extreme mental disturbance” at the time of the shooting.

On the prosecution side, authorities accuse Mangione of meticulously plotting the murder for months, even keeping a diary of his intentions and traveling across the country before allegedly attacking Thompson in Manhattan.

During a hearing on Wednesday, Agnifilo protested Judge Caro’s decision to release details of the psychiatric application. She highlighted that using “extreme emotional turmoil” as a defense is not valid in the federal legal system, arguing that disclosing these details could unfairly prejudice Mangione in a parallel federal case.

Mangione has pleaded not guilty to all state and federal charges. His New York murder trial is still set to commence on September 8, while the federal lawsuit is anticipated to continue into 2027.